Review
doi: 10.1007/978-1-4615-3872-1_8.
Clinical implications of multidrug resistance to chemotherapy
- PMID: 1686716
- DOI: 10.1007/978-1-4615-3872-1_8
Item in Clipboard
Review
Clinical implications of multidrug resistance to chemotherapy
Cancer Treat Res.
1991.
No abstract available
Similar articles
-
Modulators of P-glycoprotein-associated multidrug resistance.Cancer Treat Res. 1991;57:151-70. doi: 10.1007/978-1-4615-3872-1_7. Cancer Treat Res. 1991. PMID: 1686715 Review. No abstract available.
-
Reversal of multidrug resistance.Cancer Treat Rev. 1990 Dec;17 Suppl A:37-43. doi: 10.1016/0305-7372(90)90014-7. Cancer Treat Rev. 1990. PMID: 1982642 Review. No abstract available.
-
Multidrug resistance in leukaemia.Baillieres Clin Haematol. 1992 Oct;5(4):943-60. doi: 10.1016/s0950-3536(11)80053-3. Baillieres Clin Haematol. 1992. PMID: 1364045 Review.
-
Flow cytometric assays of anticancer drug resistance.Ann N Y Acad Sci. 1993 Mar 20;677:341-53. doi: 10.1111/j.1749-6632.1993.tb38789.x. Ann N Y Acad Sci. 1993. PMID: 8098593 Review. No abstract available.
-
Multidrug resistance: P-glycoprotein and its allies--the elusive foes.J Natl Cancer Inst. 1989 Jun 21;81(12):910-3. doi: 10.1093/jnci/81.12.910. J Natl Cancer Inst. 1989. PMID: 2567356 Clinical Trial. No abstract available.
Cited by
-
P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.Br J Cancer. 1995 Aug;72(2):307-11. doi: 10.1038/bjc.1995.329. Br J Cancer. 1995. PMID: 7640210 Free PMC article.